Ascorbic Acid (Vitamin C) as a Targeted Pro-Oxidant Therapy for Cancer

Document Type


Publication Date



Daniel A. Monti, MD is Director of the Jefferson Myrna Brind Center of Integrative Medicine and Associate Professor of Emergency Medicine and Psychiatry, Thomas Jefferson University Hospital. He is the Principal Investigator of two current clinical trials on high dose, intravenous Vitamin C.

This lecture was delivered as part of the Jefferson-Myrna Brind Center of Integrative Medicine's Grand Rounds series on March 1, 2011. Copyright 2008 by Daniel A. Monti, MD.

The presentation lasts approximately 48 minutes.


Overall goals and objectives:

1. Identify recent advances in integrative medical care and discuss their application to clinical practice.

2. Describe the latest data on complementary and alternative medical therapies that could improve patient outcomes.

3. Discuss core integrative medicine topics that patients frequently ask physicians about.